Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129161
What this trial is testing

Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sun Yat-sen University 66
Testing effectiveness (Phase 2)Looking for participantsNCT05104788
What this trial is testing

Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 27
Testing effectiveness (Phase 2)UnknownNCT05892237
What this trial is testing

CIETAI and Sequential Radiotherapy in Squamous Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Dong Wang 50
Testing effectiveness (Phase 2)Study completedNCT00039507
What this trial is testing

Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07031154
What this trial is testing

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerAdebrelimabApatinib
The First Affiliated Hospital of Xiamen University 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07182708
What this trial is testing

High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)EGFR Activating MutationResectable Lung Non-Small Cell Carcinoma
Peking University Cancer Hospital & Institute 62
Testing effectiveness (Phase 2)Looking for participantsNCT06467617
What this trial is testing

Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Beijing Chest Hospital, Capital Medical University 35
Testing effectiveness (Phase 2)WithdrawnNCT03574649
What this trial is testing

QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07550920
What this trial is testing

Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2)

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 18
Testing effectiveness (Phase 2)UnknownNCT05380024
What this trial is testing

Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 10
Testing effectiveness (Phase 2)Looking for participantsNCT05061550
What this trial is testing

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 630
Testing effectiveness (Phase 2)UnknownNCT01784549
What this trial is testing

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 168
Not applicableUnknownNCT05991206
What this trial is testing

A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC

Who this might be right for
NSCLC
Hunan Province Tumor Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472478
What this trial is testing

Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)

Who this might be right for
Lung Cancer (NSCLC)KRAS G12C Lung Cancer
Guangdong Provincial People's Hospital 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07622706
What this trial is testing

Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma

Who this might be right for
NSCLCEGFR Positive Non-small Cell Lung CancerNeoadjuvant Therapy
Peking University Cancer Hospital & Institute 60
Early research (Phase 1)UnknownNCT00006212
What this trial is testing

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Center for Molecular Medicine
Post-approval studies (Phase 4)Looking for participantsNCT07754812
What this trial is testing

Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Shanghai Pulmonary Hospital, Shanghai, China 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07829744
What this trial is testing

Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Zhongshan Hospital 190
Large-scale testing (Phase 3)Study completedNCT03456063
What this trial is testing

Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Who this might be right for
Non-Small-Cell Lung
Hoffmann-La Roche 453
Testing effectiveness (Phase 2)Active Not RecruitingNCT02259621
What this trial is testing

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 39
Next Page